Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 4.


Giannoudis, Athina ORCID: 0000-0002-7200-1497, Malki, Mohammed Imad, Rudraraju, Bharath, Mohhamed, Hisham, Menon, Suraj, Liloglou, Triantafillos ORCID: 0000-0003-0460-1404, Ali, Simak, Carroll, Jason S and Palmieri, Carlo ORCID: 0000-0001-9496-2718
(2020) Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer. Breast Cancer Research, 22 (1).


Page, Karen, Martinson, Luke J, Fernandez-Garcia, Daniel, Hills, Allison, Gleason, Kelly LT, Gray, Molly C, Rushton, Amelia J, Nteliopoulos, Georgios, Hastings, Robert K, Goddard, Kate
et al (show 10 more authors) (2021) Circulating Tumor DNA Profiling From Breast Cancer Screening Through to Metastatic Disease. JCO PRECISION ONCOLOGY, 5 (5). pp. 1768-1776.


Szijgyarto, Zsolt, Flach, Koen D, Opdam, Mark, Palmieri, Carlo ORCID: 0000-0001-9496-2718, Linn, Sabine C, Wesseling, Jelle, Ali, Simak, Bliss, Judith M, Cheang, Maggie Chon U, Zwart, Wilbert
et al (show 1 more authors) (2019) Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIES. BREAST CANCER RESEARCH AND TREATMENT, 175 (1). 149 - 163.


Giannoudis, Athina ORCID: 0000-0002-7200-1497, Malki, Mohammed I, Mohammed, Hisham, Rudraraju, Bharath, Menon, Suraj, Ali, Simak, Carroll, Jason S and Palmieri, Carlo ORCID: 0000-0001-9496-2718
(2020) The regulatory role of activating transcription factor-2 (ATF2) in modulating tamoxifen resistance in estrogen-receptor positive breast cancer. .

This list was generated on Tue Nov 1 03:01:37 2022 GMT.